로딩 중…
지수 로딩 중…
Regencell Bioscience Holdings Limited
RGC· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
HK
HK$12.01-18.96%
2026-06-18
Price Chart
Regencell Bioscience Holdings Limited-81.04%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $5.94B |
| Revenue | $0.00 |
| Net Income | $-4M |
| Total Assets | $6M |
| Net Assets | $5M |
| Value | |
| FCF Yield | -0.05% |
| Profitability | |
| ROE | -73.75% |
| ROA | -62.27% |
| Financial Health | |
| Debt Ratio | 18.42% |
| Total Debt | $544415.00 |
| FCF | $-3M |
| Cash | $2M |
| Current Ratio | 7.39x |
| Performance | |
| 1Y Return | -81.04% |
| 1M Return | -55.52% |
| From 52W High | -82.59% |
| 1Y MDD | -86.72% |
| Trading | |
| Volume | 375,879 shares |
| Trading Value | $5M |
| Per Share | |
| EPS | $-0.01 |
| BPS | $0.01 |